Welcome to our dedicated page for Neogen news (Ticker: NEOG), a resource for investors and traders seeking the latest updates and insights on Neogen stock.
Neogen Corporation (NASDAQ: NEOG) generates a steady flow of news related to food safety, animal safety, and global food security. As a Lansing, Michigan-based manufacturer of diagnostics and related products, Neogen regularly issues updates on its financial performance, segment trends, and strategic actions that affect the Food Safety and Animal Safety markets.
On this page, readers can follow earnings releases where Neogen reports revenue, segment performance, gross margin, and non-GAAP measures such as adjusted EBITDA. These updates often break out results for the Food Safety and Animal Safety segments, discuss core revenue trends versus divestitures and discontinued product lines, and provide commentary on product categories like pathogen detection, indicator testing, culture media, biosecurity, and genomics.
Neogen’s news flow also includes announcements about leadership changes, such as the appointment of a new President and Chief Executive Officer, Chief Financial Officer, and senior commercial and business unit leaders. Board transitions, including director retirements and new director appointments, are disclosed through both press releases and related SEC filings.
Sector-specific items appear in Neogen’s news as well, including collaborations in equine health and vaccine offerings such as BotVax B for botulism Type B in horses. The company also announces participation in investor conferences and the timing of quarterly earnings calls and webcasts.
By reviewing the NEOG news feed on this page, investors and observers can track how Neogen describes its progress in food safety, livestock, and pet health and wellness, as well as its strategic transformation efforts, restructuring actions, and capital allocation decisions over time.
Neogen Corporation (NASDAQ: NEOG) announced that Health Canada has approved its disinfectant, Neogen Viroxide Super, for distribution in Canada. This peroxygen-based powder disinfectant offers rapid broad-spectrum effectiveness against various bacteria and viruses, including COVID-19 and avian influenza. The product is designed for use in agricultural and aquaculture settings, enhancing biosecurity measures. Neogen's commitment to biosecurity is underscored by its comprehensive suite of cleaning and disinfectant products.
Neogen Corporation (NASDAQ: NEOG) has launched Prozap Gamma-Defense, a new micro-encapsulated, slow-release insecticide aimed at poultry producers. This powerful solution targets pests like litter beetles and flies, utilizing gamma-cyhalothrin, a potent pyrethroid. One quart can treat up to 48,000 square feet and is effective in both poultry housing and outdoor settings. Neogen, recognized for its commitment to food and animal safety, continues to expand its insecticide portfolio to support livestock management.
On May 18, 2022, Neogen Corporation (NASDAQ: NEOG) announced the launch of an enhanced Veratox assay for peanut allergen detection. This new assay, known as Veratox VIP for Peanut, improves sensitivity down to 0.25 ppm, allowing for rapid quantification of peanut protein residues in various food products and cleaning processes. The assay's unique antibody combination and modified extraction process enable flexibility in testing across different food manufacturing environments. The launch aims to address the growing demand for safe plant-based foods amidst rising peanut allergy concerns.
NEOGEN Corporation (NASDAQ: NEOG) and Gencove have launched InfiniSEEK™, a groundbreaking solution that integrates low-pass whole genome sequencing and high-coverage genotyping. This innovative technology aims to enhance cattle breeding by providing genomic insights with over 99% accuracy compared to deep genome sequencing. InfiniSEEK minimizes selection bias, facilitates the discovery of new traits, and efficiently manages over 400 bovine genetic traits. This product represents NEOGEN's commitment to offering advanced genomic technologies in the agrigenomics sector.
NEOGEN Corporation (NASDAQ: NEOG) and FOXO Technologies, Inc. have partnered on a significant research initiative exploring the links between epigenetic aging and various health factors. This project taps into the extensive Physicians' Health Study database, analyzing over 11,000 blood samples to create one of the largest epigenetic datasets. The collaboration aims to enhance understanding of lifestyle impacts on health outcomes, contributing to advancements in longevity science.
NEOGEN Corporation (NASDAQ: NEOG) has achieved a CLIA Certificate of Compliance for its genomics business in Lincoln, Nebraska, allowing it to conduct human genome testing. This certification enables NEOGEN to engage in extensive clinical research and genetic variant screening, enhancing its service offerings and participation in epigenome-wide association studies. NEOGEN's CEO, John Adent, highlighted this as a step towards innovative solutions for global customers, while Dr. Jason Lilly emphasized the company's commitment to quality standards in biological testing.
NEOGEN Corporation (NASDAQ: NEOG) has launched the Prozap Protectus Pour-On Insecticide – IGR, a new insect control product for beef cattle. This ready-to-use formula employs a triple-active approach, combining an insect growth regulator (IGR), adulticide, and a synergist to effectively target lice and various fly species. It is designed for easy application and provides season-long control with just one treatment. The product contains 3% diflubenzuron, 2.5% piperonyl butoxide, and 0.5% lambda-cyhalothrin, offering beef producers a more efficient and time-saving solution for insect management.
Summary not available.
Neogen Corporation (NEOG) reported third-quarter revenues of $128.2 million, marking a 10% year-over-year increase, with year-to-date revenues up 14%. Net income for the quarter was $5.4 million, adversely affected by $10.6 million in costs related to the merger with 3M's Food Safety business. Gross margins decreased to 44.8%, impacted by rising raw material costs and a shift toward lower-margin products. Both Food Safety and Animal Safety segments experienced revenue growth, while international revenues rose 10%, though China saw a 17% decline due to COVID-19 restrictions.
NEOGEN Corporation (NASDAQ: NEOG) has launched a ready-to-use formulation of its Synergize® disinfectant, enhancing its biosecurity product line. This new formulation simplifies application for users, requiring no mixing and reducing the need for personal protective equipment. The disinfectant effectively eliminates a range of pathogens, including those responsible for avian influenza and COVID-19. NEOGEN aims to streamline processes and reduce costs for producers in animal agriculture, particularly amid high turnover rates and stringent safety requirements.